250
M. Valentini et al. / Journal of Organometallic Chemistry 587 (1999) 244–251
CH-i-Pr and H-4), 1.71 (m, H-4%, H-7, and H-7%),
1.13 (d, 3JHH=6.8, Me), 0.87 (d, 3JHH=6.8, Me).
13C-NMR (CD2Cl2, 298 K, 400 MHz): 99.1 (q,
1JRhC=8.1, 2JPC=12.4, C-1), 97.6 (q, 1JRhC=8.7,
4.2.4. Complex 12
This ferrocene complex was prepared in a similar
manner to 16. From 20 mg of the [Rh(1,5-COD)2]BF4
and 30 mg of 7 were obtained 38 mg (86%) of the
product. Anal. Calc. for C44H56BF4P2FeRh (892.43): C,
59.22; H, 6.32. Found: C, 59.05; H, 6.39. MS (FAB):
1
2JPC=11.2, C-2), 82.5 (d, JRhC=12.4, C-5), 77.4 (d,
1JRhC=12.2, C-6), 72.3 (s, CHN), 71.9 (s, CHO), 32.2
(s, CH-i-Pr), 30.6 (s, C-4), 30.5 (s, C-7), 29.5 (s, C-8),
29.3 (s, C-3), 20.9 (s, Me), 15.7 (s, Me). 31P-NMR
805 (M+ꢀBF4−) (62.4), 695 (100). H-NMR (CD2Cl2,
1
298 K, 400 MHz): 5.56 (br, H-1), 5.36 (br, H-2), 4.32
(br, H-5), 3.86 (br, Cp), 3.32 (H-6), 2.43 (m, H-4 and
H-4%), 2.34 (m, H-3%), 2.20 (m, H-3), 1.79 (m, H-8), 1.77
(m, H-7 and H-7%), 1.28 (m, H-8%). 13C-NMR (CD2Cl2,
298 K, 400 MHz): 101.2 (s, C-6), 97.6 (s, C-1), 95.8 (s,
C-5), 93.3 (s, C-2), 71.8 (s, Cp). 31P-NMR (CD2Cl2, 298
K, 400 MHz): 53.5 (d, 1JRhP=150, PCy2), 21.4 (q,
1JRhP=149, 2JPP=32, Pph2). 103Rh-NMR (CD2Cl2,
1
(CD2Cl2, 298 K, 400 MHz): 21.7 (d, JRhP=147 Hz).
4.2.2. Complex 15b
This was prepared in similar manner to 15a using
[Ir(COD)2]BF4 (25 mg, 0.05 mmol). Yield: 45 mg,
95%. MS (FAB): 845 (M+ꢀBF4−) (100). Single crystal
suitable for X-ray diffraction was obtained from
CH2Cl2ꢀether. Anal. Calc. for C46H44NOBF4PIr
(936.86): C, 58.97; H, 4.73; N, 1.50. Found: C, 58.83;
1
1
298 K, 400 MHz): −229 (t, JRhP=150, JRhP=148).
H, 4.85; N, 1.53. 1H-NMR (CD2Cl2, 298 K, 400
4.2.5. Complex 14
2
MHz): 5.22 (br, H-1), 4.42 (br, H-2), 4.18 (t, JHH
=
This was kindly provided by Dr H. Ru¨egger [29].
1H-NMR (CD2Cl2, 298 K, 400 MHz): 4.47 (br, H-1
and H-2), 3.61 (br, H-5 and H-6), 2.48 (s, Me), 2.40
(m, H-8 and H-8%), 1.67 (m, H-4 and H-4%), 1.44 (m,
H-3 and H-3%), 1.25 (m, H-7 and H-7%), 0.43 (s, BꢀMe).
13C-NMR (CD2Cl2, 298 K, 400 MHz): 80.2 (8s, C-5
and C-6), 78.0 (s, C-1 and C-2), 30.4 (s, C-8), 30.3 (s,
C-4), 29.0 (s, C-7), 28.8 (s, C-3), 15.1 (s, Me), 11.6 (s,
B-Me). 103Rh-NMR (CD2Cl2, 298 K, 400 MHz): 1134
(s).
10.6, 3JHH=9.3, cis CHO), 3.72 (t, 2JHH=10.6,
3JHH=9.4, trans CHO), 3.39 (m, CHN), 3.06 (br,
H-6), 2.97 (br, H-5), 2.24 (m, H-8), 2.19 (m, CH-i-
Pr), 2.05 (m, H-3), 1.95 (m, H-8% and H-4), 1.77 (m,
3
H-4%), 1.70 (m, H-7), 1.58 (m, H-3%), 1.38 (d, JHH
=
6.7, Me), 1.34 (m, H-7%), 0.92 (d, 3JHH=6.7, Me).
2
13C-NMR (CD2Cl2, 298 K, 400 MHz): 89.7 (d, JPC
=
2
10.7, C-1), 82.4 (d, JPC=15.0, C-2), 74.9 (s, CHN),
72.8 (s, C-5), 72.6 (s, CHO), 62.4 (s, C-6), 34.4 (s,
C-4), 32.6 (s, C-8), 30.6 (s, CH-i-Pr), 29.2 (s, C-7),
28.1 (s, C-3), 22.6 (s, Me), 16.7 (s, Me). 31P-NMR
(CD2Cl2, 298 K, 400 MHz): 18.5 (s).
5. Supplementary material
4.2.3. Complex 16
Two full numbering schemes for the diffraction re-
sults on 15a and 15b (2 pages), plus tables of atomic
coordinates, bond lengths, bond angles, anisotropic
displacement parameters and hydrogen coordinates for
15a and 15b (17 pages) are available on request from
the author.
A solution of [Rh(COD)2]BF4 (20 mg, 0.05 mmol)
and ligand 11 (25 mg, 0.05 mmol) in CH2Cl2 (2 ml) was
stirred at r.t. for 2 h. The solvent was evaporated i.v.
and the residue was washed with hexane. Complex 16
was obtained as small needles from CH2Cl2ꢀether.
Yield: 30 mg, 77%. MS (FAB): 707 (M+ꢀBF4−) (100).
Anal. Calc. for C38H37O3BF4PSRh (794.46): C, 57.45;
1
H, 4.96. Found: C, 57.34; H, 4.91. H-NMR (CD2Cl2,
Acknowledgements
298 K, 400 MHz): 5.92 (m, CHO), 5.95 (br, H-2), 5.74
(br, H-1), 5.10 (br, H-5), 3.67 (br, H-6), 3.48 (br d,
2JHH=13.9, cis SCH2), 3.37 (m, CH2ꢀEt), 3.17 (m,
CH2ꢀEt), 2.83 (q, 2JHH=14.0, 3JHH=11.0, trans
SCH2), 2.60 (m, H-3 and H-4), 2.49 (m, H-8 and H-8%),
2.45 (m, H-4%), 2.38 (m, H-3%), 2.20 (m, H-7%), 2.03 (m,
H-7), 1.66 (t, 3JHH=7.4, 3JHH=7.7, Me). 13C-NMR
P.S.P. thanks the Swiss National Science Foundation
and the ETH Zurich for financial support. We also
thank F. Hoffmann–La Roche AG, Basel, for the
MeOꢀBiphep ligand, Professor A. Togni for ferrocene
ligand 7 as well as Johnson Matthey for the loan of
RhCl3. Special thanks are due Dr Heinz Ru¨egger for
the loan of complex 14 and for helpful discussions.
1
(CD2Cl2, 298 K, 400 MHz): 116.5 (q, J(Rh,C), 5.0,
2J(P,C), 12.9, C-2), 113.6 (q, 1J(Rh,C), 5.7, 2J(P,C),
12.9, C-1), 92.1 (d, 1J(Rh,C), 10.1, C-5), 86.6 (d,
1J(Rh,C), 9.2, C-6), 80.1 (s, CHO), 40.8 (s, SCH2), 35.8
(s, CH2ꢀEt), 32.0 (s, C-8), 31.4 (s, C-7), 28.9 (s, C-4),
28.7 (s, C-3), 15.2 (s, Me) 31P-NMR (CD2Cl2, 298 K,
400 MHz): 137.6 (d, 1JRhP=195). 103Rh-NMR
References
[1] (a) J.M. Brown, Chem. Soc. Rev. (1993) 25. (b) J.A. Ramsden,
T.D.W. Claridge, J.M. Brown, J. Chem. Soc. Chem. Commun.
1
(CD2Cl2, 298 K, 400 MHz): −204 (d, JRhP=190).